Skip to Content
Merck
CN
  • Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis.

Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis.

Annals of hematology (2013-10-31)
Cheng-Han Wu, Po-Liang Lu, Hui-Hua Hsiao, Ta-Chih Liu, Sheng-Fung Lin, Chao-Sung Chang, Jui-Feng Hsu, Yi-Chang Liu
PMID24170227
MATERIALS
Product Number
Brand
Product Description
C6645
Sigma-Aldrich
Cytosine β-D-arabinofuranoside hydrochloride, crystalline
C1768
Sigma-Aldrich
Cytosine β-D-arabinofuranoside, crystalline, ≥90% (HPLC)
A9528
Sigma-Aldrich
Amphotericin B solubilized, powder, γ-irradiated, BioXtra, suitable for cell culture
C3350000
Cytarabine, European Pharmacopoeia (EP) Reference Standard
A4888
Sigma-Aldrich
Amphotericin B from Streptomyces sp., ~80% (HPLC), powder
A2942
Sigma-Aldrich
Amphotericin B solution, 250 μg/mL in deionized water, 0.1 μm filtered, BioReagent, suitable for cell culture
Y0001014
Amphotericin B for peak identification, European Pharmacopoeia (EP) Reference Standard
A2411
Sigma-Aldrich
Amphotericin B from Streptomyces sp., BioReagent, suitable for cell culture, ~80% (HPLC)
Y0000005
Amphotericin B, European Pharmacopoeia (EP) Reference Standard
V900339
Sigma-Aldrich
Cytosine β-D-arabinofuranoside, Vetec™, reagent grade, 90%